Lung Cancer in Patients with Tuberculosis
Overview
Oncology
Affiliations
Background: Coexistent lung cancer and pulmonary tuberculosis is an urgent problem of thoracic surgery presenting a challenging task for diagnosis and surgical treatment.
Materials And Methods: From 1990 to 2005, 2218 patients with lung cancer underwent surgical treatment in Department of Thoracic Surgery and Oncology, Institute of Oncology, Vilnius University. In 46 (2.1%) patients coexistence of lung cancer and tuberculosis was found. Central lung cancer was diagnosed in 37 (80.4%) and peripheral--in 9 (19.6%) patients. Epidermoid cancer was diagnosed in 24 (52.2%) patients, adenocarcinoma--in 10 (21.7%) and adenoepidermoid carcinoma--in 12 (26.1%) patients. Stage I cancer was diagnosed in 12 (26.1%), stage II--in 11 (23.9%), and stage IIIA--in 23 (50%) patients.
Results: Pneumonectomy was performed in 18 (39.2%), lobectomy in 10 (21.7%), bilobectomy in 10 (21.7%), segmentectomy in 8 (17.4%) patients. Postoperative surgical complications were observed in 9 (19.5%) patients, non-surgical complications occurred in 19 patients (41.3%). Six patients (13.04%) died. Combined treatment was applied to 23 (50%) patients.
Conclusion: Coexistence of tuberculosis and lung cancer in thoracic surgery is fairly rare. This combination was diagnosed only in 46 cases (2.1%) out of 2218 operated lung cancer patients. Epidermoid carcinoma and stage IIIA disease was diagnosed in 50% of patients. Postoperative surgical complications occurred in 9 patients (19.5%) with lung cancer and tuberculosis. Six patients (13%) died in postoperative period. Surgery is the method of choice in treatment of combination of tuberculosis and lung cancer. Median survival of these patients was 28 +/- 2 months.
Sheikhpour M, Mirbahari S, Sadr M, Maleki M, Arabi M, Abolfathi H Tanaffos. 2023; 22(1):7-18.
PMID: 37920308 PMC: 10618578.
Yang L, Zhuang L, Ye Z, Li L, Guan J, Gong W iScience. 2023; 26(10):107881.
PMID: 37841590 PMC: 10570004. DOI: 10.1016/j.isci.2023.107881.
New progress of tuberculosis scar carcinoma.
Sun W, Liu Y, Zhao L, Wang H, Ye L, Liu X Cancer Metastasis Rev. 2023; 42(3):653-659.
PMID: 37582896 PMC: 10584710. DOI: 10.1007/s10555-023-10128-9.
Antimicrobial peptides as drugs with double response against coinfections in lung cancer.
Polinario G, Primo L, Rosa M, Dett F, Barbugli P, Roque-Borda C Front Microbiol. 2023; 14:1183247.
PMID: 37342560 PMC: 10277934. DOI: 10.3389/fmicb.2023.1183247.
Risk Factors for Pulmonary Tuberculosis in Patients with Lung Cancer: A Retrospective Cohort Study.
Liao K, Shu C, Liang F, Chen Y, Yu C, Wang J J Cancer. 2023; 14(4):657-664.
PMID: 37057286 PMC: 10088535. DOI: 10.7150/jca.81616.